文献速递脑血管病

急性卒中血管内取栓患者的血脑屏障通透性与炎症标志物动力学

Blood-Brain Barrier Permeability and Kinetics of Inflammatory Markers in Acute Stroke Patients Treated With Thrombectomy.
PubMed 文献 · Neurology · 2023-06-08

本研究在105例接受机械取栓的急性缺血性卒中患者中,探讨基线血脑屏障通透性(K2值)与循环炎症标志物动力学的关系。结果显示,血脑屏障通透性增高与更大的缺血核心体积相关(OR 1.04);在症状发作<6小时亚组(n=72)中,通透性增高还与H0时MMP-9水平升高独立相关(OR 1.33)。

要点

  • 血脑屏障通透性增高与更大的基线缺血核心体积独立相关(OR 1.04)。
  • 症状发作<6小时者中,通透性增高与H0时MMP-9水平独立相关(OR 1.33)。
  • 通透性增高者H48时MMP-9和CRP更高、侧支循环更差、出血转化更多。

核心结论

  • 在急性缺血性卒中患者中,血脑屏障通透性增高与更大的缺血核心体积相关。
  • 在症状发作<6小时的患者亚组中,血脑屏障通透性增高与更高的H0时MMP-9水平和更大的缺血核心体积独立相关。

研究设计与样本

  • 研究纳入接受机械取栓、入院MRI检查并连续评估循环炎症标志物的急性缺血性卒中患者,共105例。
  • 基线动态磁敏感灌注MRI经到达时间校正生成K2图以反映血脑屏障通透性,取基线缺血核心内K2第90百分位值与对侧正常白质比较的百分比变化,按K2中位数将人群二分为两组。
  • 采用单因素和多因素logistic回归分析,在全人群及症状发作<6小时患者中探究与治疗前血脑屏障通透性增高相关的因素。

主要发现

  • 全人群(n=105,K2中位数1.59)中,血脑屏障通透性增高者H48时MMP-9(p=0.02)和CRP(p=0.01)血清水平更高、侧支循环更差(p=0.01)、基线缺血核心更大(p<0.001)。
  • 全人群中,血脑屏障通透性增高者更易发生出血转化(p=0.008)、最终梗死体积更大(p=0.02)、3个月神经功能结局更差(p=0.04)。
  • 全人群多因素logistic回归显示,血脑屏障通透性增高仅与缺血核心体积相关(OR 1.04,95%CI 1.01-1.06,p<0.0001)。
  • 症状发作<6小时亚组(n=72,K2中位数1.27)中,血脑屏障通透性增高者H0(p=0.005)、H6(p=0.004)、H24(p=0.02)、H48(p=0.01)时MMP-9水平更高,H48时CRP更高(p=0.02),基线缺血核心更大(p<0.0001)。
  • 该亚组多因素logistic分析显示,血脑屏障通透性增高与更高的H0时MMP-9水平(OR 1.33,95%CI 1.12-1.65,p=0.01)和更大的缺血核心(OR 1.27,95%CI 1.08-1.59,p=0.04)独立相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: The aim of this study was to investigate the relationship between baseline blood-brain barrier (BBB) permeability and the kinetics of circulating inflammatory markers in a cohort of acute ischemic stroke (AIS) patients treated with mechanical thrombectomy. METHODS: The CoHort of Patients to Identify Biological and Imaging markerS of CardiovascUlar Outcomes in Stroke includes AIS patients treated with mechanical thrombectomy after admission MRI and undergoing a sequential assessment of circulating inflammatory markers. Baseline dynamic susceptibility perfusion MRI was postprocessed with arrival time correction to provide K2 maps reflecting BBB permeability. After coregistration of apparent diffusion coefficient and K2 maps, the 90th percentile of K2 value was extracted within baseline ischemic core and expressed as a percentage change compared with contralateral normal-appearing white matter. Population was dichotomized according to the median K2 value. Univariable and multiple variable logistic regression analyses were performed to investigate factors associated with increased pretreatment BBB permeability in the whole population and in patients with symptom onset <6 hours. RESULTS: In the whole population (n = 105 patients, median K2 = 1.59), patients with an increased BBB permeability had higher serum levels of matrix metalloproteinase (MMP)-9 at H48 (p = 0.02), a higher C-reactive protein (CRP) serum level at H48 (p = 0.01), poorer collateral status (p = 0.01), and a larger baseline ischemic core (p < 0.001). They were more likely to have hemorrhagic transformation (p = 0.008), larger final lesion volume (p = 0.02), and worst neurologic outcome at 3 months (p = 0.04). The multiple variable logistic regression indicated that an increased BBB permeability was associated only with ischemic core volume (odds ratio [OR] 1.04, 95% CI 1.01-1.06, p < 0.0001). Restricting analysis to patients with symptom onset <6 hours (n = 72, median K2 = 1.27), participants with an increased BBB permeability had higher serum levels of MMP-9 at H0 (p = 0.005), H6 (p = 0.004), H24 (p = 0.02), and H48 (p = 0.01), higher CRP levels at H48 (p = 0.02), and a larger baseline ischemic core (p < 0.0001). The multiple variable logistic analysis showed that increased BBB permeability was independently associated with higher H0 MMP-9 levels (OR 1.33, 95% CI 1.12-1.65, p = 0.01) and a larger ischemic core (OR 1.27, 95% CI 1.08-1.59, p = 0.04). DISCUSSION: In AIS patients, increased BBB permeability is associated with a larger ischemic core. In the subgroup of patients with symptom onset <6 hours, increased BBB permeability is independently associated with higher H0 MMP-9 levels and a larger ischemic core.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Bani-Sadr A, Mechtouff L, De Bourguignon C, et al. Blood-Brain Barrier Permeability and Kinetics of Inflammatory Markers in Acute Stroke Patients Treated With Thrombectomy. Neurology. 2023. PMID: 37290975. doi:10.1212/WNL.0000000000207460

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。